Minori MI Ishii Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Combination therapy of highly activated natural killer cells and anti-disialoganglioside (GD2) antibody for Neuroblastoma: An experimental study — Poster Session 2 with wine & cheese